Magnetar Financial’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Magnetar Financial’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,484,708	Closed	-$35.8M	–	761
2023 Q1	$35.8M	Buy	+1,484,708	New	+$18.6M	0.7%	43

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Magnetar Financial's PRVB Position: Q2 2023 in Review

Magnetar Financial sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,484,708 shares — an estimated $35.8M sold.

Magnetar Financial first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $35.8M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Magnetar Financial reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Magnetar Financial sold 1,484,708 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $35.8M.
Magnetar Financial first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Magnetar Financial's Provention Bio, Inc. Common Stock position peaked at $35.8M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Magnetar Financial's 13F filing for Q2 2023, filed 11 Aug 2023.